Europe\u2019s BAPS Swaminarayan Sanstha, the largest Hindu temple outside of India, is supporting their community during the coronavirus pandemic by spreading awareness of the PRINCIPLE trial of Covid-19 treatments.
More than 1000 people across the UK have signed-up to take part in the UK-wide PRINCIPLE Trial of potential community-based treatments for COVID-19, led by Oxford University.
There is no evidence to suggest a daily combination of probiotics reduces the need for antibiotics to treat acute infections in care home residents, finds a study led by Oxford University researchers published in JAMA.
Researchers from Oxford University are now enrolling participants into the first clinical trial of potential COVID-19 treatments to take place in GP practices.
The Nuffield Department of Primary Care Health Sciences at the University of Oxford and the Royal College of General Practitioners (RCGP) have joined forces with clinical system supplier EMIS Health to urgently recruit as many GP practices as possible for COVID-19 research.
More than 18 percent of over 60's have chronic kidney disease (CKD), around 44 percent of whom are undiagnosed without screening, finds a study led by Oxford University researchers.
A Europe-wide study conducted over three flu seasons finds that the antiviral drug, oseltamivir (Tamiflu\u00ae), can help people recover from flu-like illness about one-day sooner on average, with older, sicker patients who have been unwell for longer recovering two-to-three days sooner.
Hundreds of thousands of people will receive help to battle obesity and Type 2 diabetes under radical new NHS plans to trial very low calorie diets for the first time.
![\"\"](\"https://www.phc.ox.ac.uk/news/rcgp-research-paper-of-the-year-awarded-to-professor-chris-butler-importance-of-patient-and-public-involvement-ppi-in-the-success-of-the-study-recognised/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n